Annihilation of Methicillin-resistant Staphylococcus aureus via Photobleaching of Staphyloxanthin

Pu‐Ting Dong, Haroon Mohammad, Xiaoyu Wang, Jie Hui, Junjie Li, Lijia Liang, Mohamed N. Seleem, Ji‐Xin ChengBiorxiv 2017 · DOI

TL;DR

Researchers have developed a novel, drug-free method to combat Methicillin-resistant Staphylococcus aureus (MRSA) by using blue light to photobleach its protective pigment, staphyloxanthin. This process sensitizes MRSA to reactive oxygen species, leading to synergistic killing and demonstrating potential for treating drug-resistant bacterial infections.

What Problem Does This Paper Address?

The rise of antibiotic-resistant bacteria, particularly MRSA, poses a significant global health threat due to the dwindling pipeline of new antibiotics. MRSA has evolved resistance to multiple classes of drugs and employs various strategies, such as forming biofilms and residing within host cells, to evade treatment. This necessitates the exploration of alternative therapeutic approaches. This paper addresses this challenge by investigating a photonic method—using light to induce a biological effect—as a potential solution. Specifically, it focuses on targeting staphyloxanthin, a pigment that acts as an antioxidant for S. aureus, to weaken the bacteria and make it more susceptible to other killing mechanisms.

Methods

The study employed a multi-faceted approach:

  • Transient Absorption Microscopy: This technique was used to observe the photobleaching of staphyloxanthin in real-time. By analyzing the decay of signals after light exposure, the researchers could characterize the kinetics of the photobleaching process.
  • Absorption Spectroscopy: This was used to measure the absorption spectra of staphyloxanthin extracts and observe how they changed upon exposure to blue light, confirming the pigment's degradation.
  • Mass Spectrometry (MS) and Liquid Chromatography-Mass Spectrometry (LC-MS/MS): These techniques were crucial for identifying and quantifying the breakdown products of staphyloxanthin after blue light exposure, providing detailed insights into the photochemistry involved.
  • Bacterial Culture Assays: Standard methods were used to culture MRSA and assess its viability (colony-forming units, CFU) under various treatment conditions, including blue light alone, reactive oxygen species (H₂O₂) alone, and combinations thereof.
  • In Vitro Synergistic Assays: The researchers quantified the synergistic effect of blue light and H₂O₂ using a fractional bactericidal concentration index (FBCI) to determine if the combination was more effective than individual treatments.
  • Macrophage Infection Model: Murine macrophage cells were infected with MRSA to evaluate the efficacy of blue light in clearing intracellular bacteria.
  • Biofilm Assays: MRSA biofilms were grown and treated with blue light and/or H₂O₂ to assess the penetration and effectiveness of the photonic approach against these resilient structures.
  • In Vivo Mouse Wound Model: A mouse model of MRSA skin infection was used to evaluate the therapeutic potential of blue light and H₂O₂ in a living organism, assessing wound healing and bacterial burden.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Staphyloxanthin as a Photobleachable Target: The study reveals that staphyloxanthin, a pigment integral to S. aureus's defense, is highly susceptible to photobleaching by blue light. This is a significant finding as it identifies a specific, intrinsic vulnerability of the bacteria.
  • Synergistic Killing Mechanism: Photobleaching staphyloxanthin doesn't kill MRSA directly but primes it for destruction. The bleached pigment sensitizes the bacteria to reactive oxygen species (ROS), both endogenous (produced by host cells) and exogenous (like H₂O₂). This synergistic effect is far more potent than either treatment alone.
  • Drug-Free Therapy Potential: The method is entirely photonic, meaning it doesn't rely on traditional antibiotics. This is crucial given the growing problem of antibiotic resistance.
  • Broad Efficacy: The approach demonstrated effectiveness across various scenarios: in liquid cultures, within host immune cells (macrophages), in biofilms, and in a live animal model of skin infection. This suggests a versatile therapeutic strategy.
  • Mechanism of Photobleaching: The study elucidated that staphyloxanthin undergoes a second-order photobleaching process, indicating a dependence on the concentration of the chromophore.

Key Results

  • Blue light exposure at 460 nm effectively photobleached staphyloxanthin, with 90% decomposition achieved after 5 minutes of exposure (27 J/cm²).
  • Photobleaching of staphyloxanthin significantly sensitized MRSA to hydrogen peroxide (H₂O₂). A combination of blue light (108 J/cm²) and 13.2 mM H₂O₂ eradicated MRSA completely in culture.
  • The synergistic effect between blue light and H₂O₂ was quantified with a fractional concentration index (FBCI) of 0.45, indicating strong synergy.
  • In a mouse wound infection model, treatment with blue light and H₂O₂ resulted in significantly reduced MRSA burden and decreased pro-inflammatory cytokines, leading to cleaner wounds compared to untreated or fusidic acid-treated groups.
  • The treatment was effective against MRSA within macrophages and in biofilms, reducing CFU by 80% with blue light alone and 92% with blue light plus H₂O₂ in biofilms.

Limitations and Future Work

  • Photobleaching Alone is Insufficient: The study acknowledges that photobleaching staphyloxanthin alone is not sufficient to completely kill MRSA, as bacteria could recover and multiply after initial exposure. This highlights the necessity of combining it with ROS.
  • Further Characterization of Breakdown Products: While some breakdown products of staphyloxanthin were identified, the paper notes that a more in-depth analysis of other products is needed.
  • Optimization for Clinical Application: While the mouse model showed promise, further research would be required to optimize the blue light parameters (wavelength, intensity, duration) and H₂O₂ concentrations for safe and effective human clinical application.
  • Exploring Other Pigments: The authors suggest that this approach of targeting intrinsic pigments could be extended to other pathogenic microbes that possess such characteristics, opening up new avenues for antimicrobial photochemistry.

Summary updated

Abstract

Given that the dearth of new antibiotic development loads an existential burden on successful infectious disease therapy 1 , health organizations are calling for alternative approaches to combat methicillin-resistant Staphylococcus aureus (MRSA) infections. Here, we report a drug-free photonic approach to eliminate MRSA through photobleaching of staphyloxanthin, an indispensable membrane-bound antioxidant of S. aureus 2-5 . The photobleaching process, uncovered through a transient absorption imaging study and quantitated by absorption spectroscopy and mass spectrometry, decomposes staphyloxanthin and sensitizes MRSA to reactive oxygen species attack. Consequently, staphyloxanthin bleaching by low-level blue light eradicates MRSA synergistically with external or internal reactive oxygen species. The effectiveness of this synergistic therapy is validated in MRSA culture, MRSA-infected macrophage cells, S. aureus biofilms, and a mouse wound infection model. Collectively, these findings highlight broad applications of staphyloxanthin photobleaching for treatment of MRSA infections.
BibTeX
@misc{dong2017annihilation,
  author = {Pu‐Ting Dong and Haroon Mohammad and Xiaoyu Wang and Jie Hui and Junjie Li and Lijia Liang and Mohamed N. Seleem and Ji‐Xin Cheng},
  title = {{Annihilation of Methicillin-resistant <i>Staphylococcus aureus</i> via Photobleaching of Staphyloxanthin}},
  year = {2017},
  doi = {10.1101/227603},
  howpublished = {Biorxiv},
}
Figure